Skip to main content
SpringerLink
Log in

Role of leukotrienes in aspirin-induced asthma

  • Chapter
Book cover Leukotrienes

  • 59 Accesses

Abstract

Aspirin-induced asthma (AIA) is a well-defined clinical syndrome that affects about 10% of adult asthmatics and in which aspirin and several other non-steroidal anti-inflammatory drugs (NSAID) precipitate asthmatic reactions1-4. Although the onset of symptoms before puberty or after the age of 60 has been well documented, in most patients the first symptoms appear during the third or fourth decade of life. Typically, the patient experiences intense vasomotor rhinitis characterized by intermittent and profuse watery rhinorrhoea. Over a period of months or years, chronic nasal congestion appears and physical examination reveals nasal polyps. Bronchial asthma and intolerance to aspirin develop subsequently. The intolerance presents as a unique picture: within an hour after ingestion of aspirin an acute asthma attack develops, often accompanied by rhinorrhoea, conjunctival irritation and scarlet flushing of the head and neck. Aspirin is a common precipitating factor of life-threatening attacks of asthma5; in a recent large survey, 25% of asthmatic patients requiring emergency mechanical ventilation were found to be aspirin intolerant6.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968; 68: 975–83.

    Article  PubMed  CAS  Google Scholar 

  2. Stevenson DD. Diagnosis, prevention and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol. 1984; 74: 617–22.

    Article  PubMed  CAS  Google Scholar 

  3. Szczeklik A. Aspirin-induced asthma. In: Vane JR, Botting RM, editors. Aspirin and other salicylates. London: Chapman and Hall Medical, 1992: 548–75.

    Google Scholar 

  4. Szczeklik A. Mechanism of aspirin-induced asthma. Allergy. 1997; 52: 613–19.

    Article  PubMed  CAS  Google Scholar 

  5. Picado C, Castillo JA, Montserrat JM, Augusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Resp J. 1989; 2: 127–9.

    CAS  Google Scholar 

  6. Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis for near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for near-fatal attack of asthma. Am Rev Resp Dis. 1992; 146: 76–81.

    Article  PubMed  CAS  Google Scholar 

  7. Szczeklik A, Schmitz-Schumann M, Nizankowska E, Milewski M, Roehlig F, Virchow C. Altered distribution of IgG subclasses in aspirin-induced asthma: high IgG4, low IgG1. Clin Exp Allergy. 1992; 22: 283–7.

    Article  PubMed  CAS  Google Scholar 

  8. Szczeklik A, Nizankowska E, Serafin A, Dyczek A, Duplaga M, Musial J. Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Resp Crit Care Med. 1995; 152: 1753–6.

    Article  PubMed  CAS  Google Scholar 

  9. Lasalle P, Delneste Y, Gosset P, Grass-Masse H, Wallaert B, Tonne] AB T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma. Eur J Immunol. 1993; 23. 796–803.

    Article  Google Scholar 

  10. Szczeklik A, Musial J, Pulka G. Autoimmune vasculitis and aortic stenosis in aspirin-induced asthma. Allergy. 1997; 52: 352–4.

    Article  PubMed  CAS  Google Scholar 

  11. Bochenek G. Nizankowska E, Szczeklik A. Atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 1996; 51: 16–23.

    PubMed  CAS  Google Scholar 

  12. Dekker JW, Nizankowska E, Schmitz-Schumann M, et al. Aspirin-induced asthma and HLA-DRBI and HLA-DPBI genotypes. Clin Exp Allergy. 1997; 27: 574–7.

    Article  PubMed  CAS  Google Scholar 

  13. Settipane RA, Schrank PJ, Simon RA, Mathison DA, Christiansen SC, Stevenson DD. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol. 1995; 96: 480–5.

    Article  PubMed  CAS  Google Scholar 

  14. Virchow Ch, Szczeklik A, Bianco S, et al. Intolerance to tartrazine in aspirin-induced asthma: results of a multicenter study. Respiration. 1988; 53: 20–3.

    Article  PubMed  CAS  Google Scholar 

  15. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Resp J. 1990; 3: 588–93.

    CAS  Google Scholar 

  16. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 1971; 231: 232–4.

    CAS  Google Scholar 

  17. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis J Allergy Clin Immunol. 1977; 60: 276–84.

    Article  PubMed  CAS  Google Scholar 

  18. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ. 1975; 1:67–9.

    Article  PubMed  CAS  Google Scholar 

  19. Stevenson DD, Lewis RA. Proposed mechanisms of aspirin sensitivity reactions. J Allergy Clin Immunol. 1987; 80: 788–90.

    Article  PubMed  CAS  Google Scholar 

  20. Lee TH. Mechanism of aspirin sensitivity. Am Rev Resp Dis. 1992: 145: 34–6.

    Article  Google Scholar 

  21. Bazan N, Botting J, Vane JR. New targets in inflammation. Inhibitors of COX-2 or adhesion molecules. Dordrecht: Kluwer and William Harvey Press, 1996.

    Book  Google Scholar 

  22. Bianco S, Robuschi M, Petrigni G, et al. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs. 1993; 46 (suppl. 1): 115–20.

    Article  PubMed  Google Scholar 

  23. Busse WW. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy. 1996; 26: 868–79.

    Article  PubMed  CAS  Google Scholar 

  24. Sampson AP. The leukotrienes: Mediators of chronic inflammation in asthma. Clin Exp Allergy. 1996; 26: 995–1004.

    Article  PubMed  CAS  Google Scholar 

  25. Smith CM, Hawksworth RJ, Thien FC, Christie PE, Lee TH. Urinary leukotriene E4 in bronchial asthma. Eur Resp J. 1992; 5: 693–9.

    CAS  Google Scholar 

  26. Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, Lee TH Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Resp Dis. 1991; 143: 1025–9.

    Article  PubMed  CAS  Google Scholar 

  27. Kumlin M, Dahlén B, Bjorck T, Zetterstrom O, Granstrom E, Dahlén SE. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to provocations with allergen, aspirin, leukotriene D4 and histamine in asthmatics. Am Rev Resp Dis. 1992; 146: 96–103.

    Article  PubMed  CAS  Google Scholar 

  28. Sladek K, Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Resp J. 1993; 6: 391–9.

    CAS  Google Scholar 

  29. Ortolani C, Mirone C, Fontana A, et al. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann Allergy. 1987; 59: 106–12.

    PubMed  CAS  Google Scholar 

  30. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL. Release of leukotrienes, prostaglandins and histamine into nasal secretions of aspirin-sensitive asthmatic during reaction to aspirin. Am Rev Resp Dis. 1988; 137: 847–54.

    Article  PubMed  CAS  Google Scholar 

  31. Picado C, Ramis I, Rosello J, et al. Release of peptido-leukotrienes into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Resp Dis. 1992; 145: 65–9.

    Article  PubMed  CAS  Google Scholar 

  32. Kowalski ML, Sliwinska-Kowalska M, et al. Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol. 1993; 91: 580–98.

    Article  PubMed  CAS  Google Scholar 

  33. Kowalski ML, Grzegorczyk J, Wojciechowska B, Pomatowska M. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy. 1996; 26: 807–14.

    Article  PubMed  CAS  Google Scholar 

  34. Fischer AR, Rosenberg MA, Lilly CM, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol. 1994; 94: 1046–56.

    Article  PubMed  CAS  Google Scholar 

  35. Wong D-Y, Smitz J, Clement P. Prostaglandin D2 measurement in nasal secretions is not a reliable marker for mast cell activation in atopic patients. Clin Exp Allergy. 1995; 25: 1228–34.

    Article  Google Scholar 

  36. Szczeklik A, Sladek K, Dworski R, et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin sensitive asthmatics. Am J Resp Crit Care Med. 1996; 154: 1608–14.

    Article  PubMed  CAS  Google Scholar 

  37. Warren MS, Sloan SJ, Westcott JY, Hamilos D, Wenzel SE. LTE4 increases in bronchoalveolar lavage fluid (BALF) of aspirin-intolerant asthmatics (AIA) after instillation of indomethacin. J Allergy Clin Immunol. 1995; 95: 170.

    Google Scholar 

  38. Sampson AP, Coburn AS, Sladek K, et al. Profound overexpression of leukotriene C4 synthase in aspirin-intolerant asthmatic bronchial biopsies. Int Arch Allergy Immunol. 1977; 113: 355–7.

    Article  Google Scholar 

  39. Nasser SMS, Pfister R, Christie PE, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Resp Crit Care Med. 1996; 153: 90–6.

    Article  PubMed  CAS  Google Scholar 

  40. Christie PE, Smith CM, Lee TH. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Am Rev Resp Dis. 1991; 144: 957–8.

    Article  PubMed  CAS  Google Scholar 

  41. Dahlén B, Margolskee DJ, Zetterstrom O, Dahlén S-E. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects. Thorax. 1993; 48: 1205–10.

    Article  PubMed  Google Scholar 

  42. Yamamoto H, Nagata M, Kuramitsu K, et al. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am J Resp Crit Care Med. 1994; 150: 254–7.

    Article  PubMed  CAS  Google Scholar 

  43. Szczeklik A, Serwonska M. Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine. Thorax. 1979; 34: 654–7.

    Article  PubMed  CAS  Google Scholar 

  44. Philips GD, Foord R, Holgate ST. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: Its repeatability absence of a late-phase reaction and the role of histamine. J Allergy Clin Immunol. 1989; 84: 232–41.

    Article  Google Scholar 

  45. Dahlén S-E, Niiankowska E, Dahlén B, et al. The Swedish-Polish treatment study with the 5-lipoxygenase inhibitor Zileuton in aspirin-intolerant asthmatics. Am J Resp Crit Care Med. 1995; 151: A376.

    Google Scholar 

  46. Kuna P, Malmström K, Dahlén S-E, et al. Montelukast (MK-0476), a cys-LT1 receptor antagonist, improves asthma control in aspirin-intolerant asthmatic patients. Am J Resp Crit Care Med. 1997; 155: A975.

    Article  Google Scholar 

Download references

Authors
  1. A. Szczeklik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Sanak
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Merck Frosst Canada, Inc., Pointe-Claire-Dorval, Quebec, Canada

    Ian Rodger

  2. The William Harvey Research Institute, Saint Bartholomew’s Hospital Medical College, London, UK

    Jack Botting

  3. Asthma and Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Sven-Erik Dahlén

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Szczeklik, A., Sanak, M. (1998). Role of leukotrienes in aspirin-induced asthma. In: Rodger, I., Botting, J., Dahlén, SE. (eds) Leukotrienes. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4880-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4880-1_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6045-5

  • Online ISBN: 978-94-011-4880-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation